You are about to leave the Clinical Value website now.


Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis

Quick Summary

This study aimed to compare the performance of surveillance imaging with or without alpha fetoprotein (AFP) for early detection of hepatocellular carcinoma (HCC) in patients with cirrhosis. The researchers searched MEDLINE and SCOPUS and found that ultrasound alone had low sensitivity for detecting early-stage HCC, but the addition of AFP significantly increased sensitivity. The study concluded that ultrasound plus AFP measurement is a more effective surveillance strategy for detecting HCC in clinical practice. However, only a few studies evaluated computed tomography or magnetic resonance image-based surveillance, which detected HCC with high sensitivity.

You May Also Like

13 February 2024

The Pursuit for Better Patient Outcomes – Innovating HCC Management at Siriraj Hospital

Read More
7 November 2023

Value and Challenges for Precision Oncology Realisation in Real World Practice

Read More


Be the first to receive updates, event opportunities, and thought leadership insights.